Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
97 hedge funds and large institutions have $450M invested in Epizyme, Inc in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 11 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 29
2% less funds holding
Funds holding: 99 → 97 (-2)
7% less capital invested
Capital invested by funds: $485M → $450M (-$34.3M)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
87% less call options, than puts
Call options by funds: $128K | Put options by funds: $975K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
+$7.87M |
| 2 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
+$3.21M |
| 3 |
Renaissance Technologies
New York
|
+$1.51M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.21M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$7.73M |
| 2 |
Millennium Management
New York
|
-$6.03M |
| 3 |
DM
Deerfield Management
New York
|
-$3.02M |
| 4 |
SIM
Spark Investment Management
New York
|
-$2.59M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.5M |
EPZM Hedge Fund Activity: Q3 2016 in Review
97 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q3 2016, worth a combined $450M — down 7.1% from $485M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of EPZM and 9 opened new positions — a net loss of 2 holders — while 29 trimmed existing stakes and 31 added.
The largest buyer was VOYA Investment Management, adding an estimated $7.87M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $7.73M sold.
- 97 institutional investors held Epizyme, Inc (EPZM) as of Q3 2016, down from 99 in Q2 2016.
- Funds reported $450M of Epizyme, Inc stock for Q3 2016, down 7.1% quarter-over-quarter.
- 9 funds opened new Epizyme, Inc positions in Q3 2016 and 11 closed out, a net change of -2 holders.
- The largest Epizyme, Inc buyer in Q3 2016 was VOYA Investment Management, an estimated $7.87M added.
- The largest Epizyme, Inc seller in Q3 2016 was EcoR1 Capital, an estimated $7.73M sold.
Based on aggregated 13F filings for Q3 2016.